Scholar Rock Holding (SRRK) Enterprise Value (2017 - 2026)

Scholar Rock Holding's (SRRK) quarterly Enterprise Value came in at -$479.9 million in Q1 2026, down 31.72% year-on-year from -$702.9 million in Q1 2025, and down 30.57% quarter-over-quarter from -$367.6 million in Q4 2025.

Scholar Rock Holding (SRRK) Enterprise Value (2017 - 2026) Analysis & Trends

Scholar Rock Holding's Enterprise Value history runs 10 years deep, the most recent figure standing at -$479.9 million for Q1 2026.

  • On a quarterly basis, Enterprise Value fell 31.72% year-over-year to -$479.9 million in Q1 2026; TTM through Mar 2026 was -$479.9 million, a 31.72% decrease from a year earlier, with the FY2025 full-year figure at -$367.6 million, up 15.94% from the prior year.
  • Enterprise Value fell to -$479.9 million in Q1 2026 per SRRK's latest filing, from -$367.6 million in the prior quarter.
  • Across five years, Enterprise Value topped out at -$139.1 million in Q3 2024 and bottomed at -$479.9 million in Q1 2026.
  • The 5-year median for Enterprise Value is -$295.0 million (2025), against an average of -$302.6 million.
  • Across the five-year window, Enterprise Value soared 36.39% in 2024 and plunged 165.8% in 2025, its largest moves.
  • Year by year, Enterprise Value stood at -$315.4 million in 2022, then climbed by 11.23% to -$279.9 million in 2023, then plunged by 56.21% to -$437.3 million in 2024, then increased by 15.94% to -$367.6 million in 2025, then slumped by 30.57% to -$479.9 million in 2026.
  • Per Business Quant, the three latest SRRK Enterprise Value figures stand at -$479.9 million (Q1 2026), -$367.6 million (Q4 2025), and -$369.6 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Enterprise Value (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -283.54 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -61.40 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn -4.79 Bn
4 NuCana 279.75 Bn 279.75 Bn - -32.26 Mn
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -7.25 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -8.75 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -5.18 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -1.91 Bn
10 Scholar Rock Holding 6.30 Bn 6.30 Bn - -479.94 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -479.94 Mn
Dec 31, 2025 -367.56 Mn
Sep 30, 2025 -369.63 Mn
Jun 30, 2025 -295.01 Mn
Mar 31, 2025 -364.38 Mn
Dec 31, 2024 -437.28 Mn
Sep 30, 2024 -139.07 Mn
Jun 30, 2024 -190.49 Mn
Mar 31, 2024 -238.43 Mn
Dec 31, 2023 -279.94 Mn
Sep 30, 2023 -218.64 Mn
Jun 30, 2023 -248.73 Mn
Mar 31, 2023 -275.28 Mn
Dec 31, 2022 -315.36 Mn
Sep 30, 2022 -343.66 Mn
Jun 30, 2022 -370.69 Mn
Mar 31, 2022 -210.21 Mn
Dec 31, 2021 -252.99 Mn
Sep 30, 2021 -246.44 Mn
Jun 30, 2021 -282.22 Mn